Ochre Bio raises €30.0M Series A round
10 October 2022· Oxford, United Kingdom· health, biotech, rna_therapeutics, ai, machine_learning, b2b, genomics
to support the development of first candidates for IND-enabling studies, as well as expand discovery and RNA chemistry capabilities to address a wider set of serious liver-related diseases
Investors
LeadKhosla Ventures
Also participating
EIT HealthBacked VCSelvedgeHermes-EpitekLifeForce CapitalAixTheraLifeLinkAlice ZhangKristen FortneyMarty Chavez
About Ochre Bio
Stage
Series A
Headquarters
Oxford, United Kingdom
Founded
2019
Team Size
51–200
Sectors
healthbiotechrna_therapeuticsaimachine_learningb2bgenomics